Nxu, INC 8-K filings

Nxu, Inc. announced the termination of its merger agreement with Verde Bioresins, Inc., its impending delisting from Nasdaq, and a board decision to pursue an orderly winding down and dissolution of the company.

Nxu, Inc. announced its securities will be delisted from Nasdaq after failing to meet the minimum bid price requirement, despite a reverse stock split, and the company does not intend to appeal the decision.

Nxu, Inc. received a delisting notice from Nasdaq after failing to meet the minimum bid price requirement, despite a reverse stock split, and is appealing the decision.

Nxu, Inc. will implement a 1-for-20 reverse stock split of its Class A common stock, effective March 31, 2025.

Nxu, Inc. will implement a 1-for-20 reverse stock split effective March 31, 2025, to meet Nasdaq's minimum bid price requirements.

Nxu, Inc. stockholders voted to approve the merger with Verde Bioresins, along with amendments to the company's certificate of incorporation, at a special meeting held on February 11, 2025.

Nxu Inc. appoints Erin Essenmacher as an independent director to its Board and Audit Committee, effective immediately.

Nxu, Inc. has entered into a securities purchase agreement to raise approximately $3 million through a private placement of common stock and warrants.

Nxu, Inc. has announced a proposed merger with Verde Bioresins, a company focused on developing biodegradable and recyclable resins, to capitalize on the growing demand for sustainable plastic alternatives.

Nxu, Inc. has filed a registration statement for its proposed merger with Verde Bioresins, Inc., a move that will see the combined entity focus on sustainable bioplastics.

Nxu and Verde Bioresins have announced a proposed merger to combine their expertise in sustainable technology and bioplastics, aiming to disrupt the plastics industry.

Nxu, Inc. received a notice from Nasdaq regarding non-compliance with audit committee requirements due to a director's departure, potentially leading to delisting.

Nxu Inc. stockholders approved amendments to the company's charter and incentive plan, including an increase in shares available for issuance and an extension of the plan's term, at their annual meeting on August 14, 2024.

Nxu Inc. has amended its bylaws to reduce the quorum requirement for stockholder meetings from a majority to one-third of the voting power, effective July 24, 2024.

Nxu Inc. is evaluating strategic alternatives, including a potential business combination, and has initiated a significant headcount reduction to cut costs.

Caryn Nightengale will not seek reelection to the board of directors at Nxu, Inc.'s 2024 Annual Meeting of Stockholders.

Nxu Inc. received a notice from Nasdaq for non-compliance with the minimum bid price rule and has increased compensation for independent directors.

Nxu Inc. has successfully regained compliance with all Nasdaq listing requirements, resolving issues related to bid price, equity, and annual meeting rules, and avoiding potential delisting.

Nxu, Inc. is facing potential delisting from Nasdaq after failing to hold its annual shareholder meeting within the required timeframe, despite believing it was a newly listed company.